合成目标产物 Artesunate 主要起始原料 Succinic Anhydride And Alpha-Dihydroartemisinin
71939-50-9 + 81496-81-3 + 108-30-5 = 88495-63-0 反应条件:1.1 Reagents: Triethylamine Solvents: Isopropyl Acetate; 30 Min,25 °C; 4 H,25 °C1.2 Reagents: Sulfuric Acid Solvents: Water; > 1 Min,Ph 5,25 °C 标题:A Simplified And Scalable Synthesis Of Artesunate 作者:Presser,Armin; Et Al 参考文献:Monatshefte Fuer Chemie 日期:2017 卷标:148(1) 页码:63-68]
131175-87-6 + 108-30-5 = 88495-63-0 反应条件:1.1 Reagents: Triethylamine Solvents: Dichloromethane; Rt1.2 Reagents: Hydrochloric Acid Solvents: Water 标题:Continuous Synthesis Of Artemisinin-Derived Medicines 作者:Gilmore,Kerry; Et Al 参考文献:Chemical Communications (Cambridge 日期:2014 卷标:50(84) 页码:12652-12655]
81496-81-3 + 110-15-6 = 88495-63-0 反应条件:1.1 Reagents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride Catalysts: 4-(Dimethylamino)Pyridine Solvents: Dichloromethane; 4 H,0 °C 标题:Design And Synthesis Of Novel Artemisinin Derivatives With Potent Activities Against Colorectal Cancer In Vitro And In Vivo 作者:Wang,Liang-Liang; Et Al 参考文献:European Journal Of Medicinal Chemistry 日期:2019 卷标:182]
108-30-5 + 98672-75-4 = 88495-63-0 [标题:Reaction Conditions 标题:Studies On Analogs Of Arteannuin. Ii. Synthesis Of Some Carboxylic Esters And Carbonates Of Dihydroarteannuin By Using 4-(N,N-Dimethylamino)Pyridine As An Active Acylation Catalyst 作者:Li,Ying; Et Al 参考文献:Huaxue Xuebao 日期:1982 卷标:40(6) 页码:557-61]
71939-50-9 + 108-30-5 = 88495-63-0 反应条件:1.1 Reagents: Sodium Bicarbonate Solvents: Acetone; 24 H,Rt1.2 Reagents: Acetic Acid Solvents: Water; Ph 3,Rt1.3 Solvents: Water; 30 Min,Rt 标题:Synthesis Of Artesunate From Dihydroartemisinin With Sodium Bicarbonate As Catalyst 作者:Do,Huu Nghi; Et Al 参考文献:Tap Chi Duoc Hoc 日期:2008 卷标:48(4) 页码:29-31]
131175-87-6 + 108-30-5 = 88495-63-0 反应条件:1.1 Solvents: Dichloromethane; Rt1.2 Catalysts: 4-(Dimethylamino)Pyridine; 30 Min,0 - 5 °C; 5 °C -> Rt; 1 H,Rt1.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 3 标题:Synthesis Of Dihydroartemisinin-Isosorbitan Mononitrate Hybrid And Its Antitumor Activities In Vitro 作者:Xie,Bin; Et Al 参考文献:Hecheng Huaxue 日期:2011 卷标:19(1) 页码:62-65]
131175-87-6 + 108-30-5 = 88495-63-0 反应条件:1.1 Reagents: Imidazole Solvents: Dichloromethane; 2 H,Rt1.2 Reagents: Hydrochloric Acid Solvents: Water; Ph 3,Rt 标题:Structural Optimization And Biological Evaluation For Novel Artemisinin Derivatives Against Liver And Ovarian Cancers 作者:Zhou,Yu; Et Al 参考文献:European Journal Of Medicinal Chemistry 日期:2021 卷标:211]
63968-64-9 + 108-30-5 = 88495-63-0 反应条件:1.1 Reagents: Sodium Borohydride Solvents: Methanol; 2 H,0 - 5 °C1.2 Reagents: Imidazole Solvents: Dichloromethane; 2 H,Rt 标题:Reverse Chemical Proteomics Identifies An Unanticipated Human Target Of The Antimalarial Artesunate 作者:Gotsbacher,Michael P.; Et Al 参考文献:Acs Chemical Biology 日期:2019 卷标:14(4) 页码:636-643]
88495-63-0 = 88495-63-0 反应条件:1.1 Reagents: Iron Chloride (Fecl3) Solvents: Methanol; 12 H,Reflux; 24 H; Overnight,Cooled 标题:Some Transition Metal Complexes Bearing Artemisinin Derivatives And (N-N-O) Tridentate Chromium (Iii) Complexes Ligated By 2-Benzolmidazo-Yl-6-Acetyl-Pyridines For Catalytic Behaviour Towards Ethylene 作者:Obaleye,Joshua Ayoola; Et Al 参考文献:Journal Of Chemistry And Chemical Engineering 日期:2010 卷标:4(12) 页码:23-32]
131175-87-6 + 110-15-6 = 88495-63-0 反应条件:1.1 Reagents: Trichloroacetonitrile,1,8-Diazabicyclo[5.4.0]Undec-7-Ene Solvents: Dichloromethane1.2 Solvents: Dichloromethane 标题:C-10 Ester And Ether Derivatives Of Dihydroartemisinin - 10-α Artesunate,Preparation Of Authentic 10-β Artesunate,And Of Other Ester And Ether Derivatives Bearing Potential Aromatic Intercalating Groups At C-10 作者:Haynes,Richard K.; Et Al 参考文献:European Journal Of Organic Chemistry 日期:2002 卷标:(1) 页码:113-132]
专利号:WO-2013138200-A1 优先权日:2012-03-13 标 题 :Green chemistry synthesis of the malaria drug amodiaquine and analogs thereof 发明人:FORTUNAK JOSEPH MARIAN; KULKARNI AMOL ANANT; KING CHRISTOPHER 权利人:UNIV HOWARD 摘要:Methods are provided for a green chemistry one-pot synthesis of amodiaquine and amodiaquine analogs. The methods have a lower environmental impact, lower investment cost, reduced amounts of byproducts and impurities, and a shorter synthesis time, compared to current conventional synthesis methods. The methods reduce the total number of steps in the synthesis from four to five down to two, thereby simplifying production; and allow a reduced number of solvents and reagents to be used in production, thereby reducing the waste generated in the synthesis. The methods can reduce the waste to about 3-5 kilograms of waste generated per kilogram of product produced; and surprisingly improve the overall yield from 60-65% to greater than 90% as compared to the current conventional synthesis methods for amodiaquine and its analogs.
专利号:US-11738092-B2 优先权日:2019-12-04 标题:Methods and compositions for synthesis of therapeutic nanoparticles 发明人:WYENT EMILY A; BLUMENFELD CARL M; LAMM ROBERT J 权利人:DANTARI INC 摘要:Improved methods and reactants for the chemical synthesis of therapeutic nanoparticles are provided. The nanoparticles comprise a polymeric core, to which is attached one or more homing molecules and one or more therapeutic agents. Improvements in speed, yield and purity are attained using the methods disclosed herein.
专利号:WO-2010144434-A1 优先权日:2009-06-09 标题 :Derivatives of mefloquine and associated methods for making and using 发明人:DOW GEOFFREY S; MILNER ERIN E; WIPF PETER; MO TINGTING 权利人:US OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF U S; DOW GEOFFREY S; MILNER ERIN E; WIPF PETER; MO TINGTING 摘要:The present invention relates to new mefloquine derivatives and therapeutic compositions comprising one or more mefloquine derivatives. Mefloquine derivatives of the invention have a pentafluorosulfanyl moiety substitution at the 8-position. Certain mefloquine derivatives further include a quinoline methanol moiety substitution at the 4-position. The present invention also relates to new intermediate compounds useful in the synthesis of the mefloquine derivatives, which intermediates also have a pentafluorosulfanyl moiety substitution at the 8-position.
专利号:US-7947701-B2 优先权日:2003-11-14 标题:Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof 发明人:CAZELLES JEROME; COSLEDAN FREDERIC; MEUNIER BERNARD; PELLET ALAIN 权利人:SANOFI AVENTIS 摘要:The invention relates to dual molecule compounds containing a peroxide derivative, to processes for the synthesis of such compounds, to pharmaceutical compositions comprising such compounds, and to methods of treatment and prevention of malaria comprising administering such compounds and such pharmaceutical compositions.
专利号:US-7427483-B2 优先权日:2006-02-24 标题:Utilization of nucleotide probes in ELISA procedure for the quantitative determination of Plasmodium falciparum DNA in malaria 发明人:NGUYEN KHUE VU 权利人:VISTA BIOLOG CORP 摘要:The present invention is the development of a simple and specific quantitative method for the determination of P. falciparum DNA in malaria that involves the direct detection of the highly 42-kDa conserved C-terminal region of P. falciparum merozoite surface protein (MSP1) gene. This procedure entails the amplification of the 42-kDa C-terminal region of the MSP1 gene by using the PCR technique in the presence of digoxigenin-11-dUTP and the synthesis of the specific biotin labeled nucleotide probes directed to the 42-kDa C-terminal region of the MSP1 gene. These specific probes are then used in the Enzyme Linked Immunosorbent Assay (ELISA) for the quantitative determination of the 42-kDa C-terminal region of the MSP1 gene which leads to the quantitative determination of P. falciparum DNA in malaria for quantitative diagnostic purpose as well as for monitoring the efficacy of antimalarial treatment.
专利号:US-9802952-B2 优先权日:2013-07-15 标 题:Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives 发明人:KOPETZKI DANIEL; MCQUADE DAVID TYLER; SEEBERGER PETER H; GILMORE KERRY 权利人:MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V; MAX-PLANK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V 摘要:The present invention is directed to a method for continuous production of dihydroartemisinin and also artemisinin derivatives derived from dihydroartemisinin by using artemisinin or dihydroartemisinic acid (DHAA) as starting material as well as to a continuous flow reactor for producing dihydroartemisinin as well as the artemisinin derivatives. It was found that the reduction of artemisinin to dihydroartemisinin in a continuous process requires a special kind of reactor and a special combination of reagents comprising a hydride reducing agent, at least one activator such as an inorganic activator, at least one solid base, at least one aprotic solvent and at least one C 1 -C 5 alcohol.
1: Krishna S, Ganapathi S, Ster IC, Saeed ME, Cowan M, Finlayson C, Kovacsevics H, Jansen H, Kremsner PG, Efferth T, Kumar D. A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer. EBioMedicine. 2014 Nov 15;2(1):82-90. doi: 10.1016/j.ebiom.2014.11.010. eCollection 2015 Jan. 2: Okebe J, Eisenhut M. Pre-referral rectal artesunate for severe malaria. Cochrane Database Syst Rev. 2014 May 29;(5):CD009964. doi: 10.1002/14651858.CD009964.pub2. Review. 3: Ravindra KC, Ho WE, Cheng C, Godoy LC, Wishnok JS, Ong CN, Wong WS, Wogan GN, Tannenbaum SR. Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21. doi: 10.1177/0394632015589518. Epub 2015 Jul 8. doi: 10.3892/mmr.2015.3500. Epub 2015 Mar 17. doi: 10.1159/000369666. Epub 2014 Dec 8. doi: 10.1111/bcp.12660. Epub 2015 Jul 22.
合成参考文献
参考文献:10.2174/157016310791162730 摘要:Youns M, Hoheisel JD, Efferth T. Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. Curr Drug Discov Technol. 2010 Mar;7(1):37–45. doi: 10.2174/157016310791162730. 参考文献:10.1186/1475-2875-9-53 摘要:Sowunmi A, Adewoye EO, Gbotsho GO, Happi CT, Sijuade A, Folarin OA, Okuboyejo TM, Michael OS. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Malaria Journal. 2010 Feb 15;9(1):53. doi: 10.1186/1475-2875-9-53. 参考文献:10.3109/10408441003610571 摘要:Efferth T, Kaina B. Toxicity of the antimalarial artemisinin and its dervatives. Critical Reviews in Toxicology. 2010 Feb 16;40(5):405–21. doi: 10.3109/10408441003610571. 参考文献:10.1186/1475-2875-10-187 摘要:Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, Anyan WK, Osei JH, Asahi H, Ofori MF, Akao N, Wilson MD, Boakye DA, Ohta N. Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro. Malaria Journal. 2011 Jul 11;10(1):187. doi: 10.1186/1475-2875-10-187. 参考文献:10.1007/s00436-011-2534-x 摘要:Xiao SH, Sun J, Xue J, Du XL, Zhang HB. Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration. Parasitol Res. 2012 Feb;110(2):637–44. doi: 10.1007/s00436-011-2534-x.